Ajax-Loading

Sumitomo Dainippon Pharma Co Ltd - Return On Equity

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in Percent.

The item "Return-On-Equity" stands at 79.61 percent as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Return On Equity" stands at 79.61 Percent. This represents an increase of 67.53 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 223.91 compared to the value the year prior.
The Serie's long term average value is -29.08 percent. It's latest available value, on 09/30/2025, is 108.69 higher, compared to it's long term average value.
The Serie's change from it's minimum value, on 09/30/2024, to it's latest available value, on 09/30/2025, is +223.91 .
The Serie's change in percentage points from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0.

Return On Equity for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Return On Equity905,699,262,464.00
LogoJohnson & Johnson - Return On Equity486,508,953,600.00
LogoAbbVie Inc - Return On Equity399,570,305,024.00
LogoRoche Holding AG - Return On Equity317,433,206,677.55
LogoAstraZeneca PLC - Return On Equity280,205,508,085.11